Acadian Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43K | Hold |
510
| – | – | ﹤0.01% | 1869 |
|
|
2026
Q1 | $46K | Hold |
510
| – | – | ﹤0.01% | 1867 |
|
|
2025
Q4 | $45K | Hold |
510
| – | – | ﹤0.01% | 1811 |
|
|
2025
Q3 | $50K | Hold |
510
| – | – | ﹤0.01% | 1641 |
|
|
2025
Q2 | $46K | Hold |
510
| – | – | ﹤0.01% | 1494 |
|
|
2025
Q1 | $57K | Hold |
510
| – | – | ﹤0.01% | 1424 |
|
|
2024
Q4 | $53K | Hold |
510
| – | – | ﹤0.01% | 1449 |
|
|
2024
Q3 | $55K | Sell |
510
-3,062
| -86% | -$334K | ﹤0.01% | 1771 |
|
|
2024
Q2 | $386K | Buy |
3,572
+3,062
| +600% | +$361K | ﹤0.01% | 1283 |
|
|
2024
Q1 | $67K | Hold |
510
| – | – | ﹤0.01% | 1346 |
|
|
2023
Q4 | $62K | Hold |
510
| – | – | ﹤0.01% | 1436 |
|
|
2023
Q3 | $57K | Sell |
510
-37,230
| -99% | -$4.73M | ﹤0.01% | 1413 |
|
|
2023
Q2 | $5.49M | Buy |
37,740
+36,009
| +2,080% | +$4.89M | 0.02% | 432 |
|
|
2023
Q1 | $222K | Buy |
1,731
+1,221
| +239% | +$153K | ﹤0.01% | 1235 |
|
|
2022
Q4 | $65K | Hold |
510
| – | – | ﹤0.01% | 1522 |
|
|
2022
Q3 | $53K | Hold |
510
| – | – | ﹤0.01% | 1493 |
|
|
2022
Q2 | $54K | Hold |
510
| – | – | ﹤0.01% | 1486 |
|
|
2022
Q1 | $65K | Sell |
510
-15
| -3% | -$1.81K | ﹤0.01% | 1436 |
|
|
2021
Q4 | $64K | Sell |
525
-272
| -34% | -$35.6K | ﹤0.01% | 1457 |
|
|
2021
Q3 | $113K | Sell |
797
-883
| -53% | -$130K | ﹤0.01% | 1419 |
|
|
2021
Q2 | $262K | Buy |
1,680
+718
| +75% | +$116K | ﹤0.01% | 1362 |
|
|
2021
Q1 | $150K | Sell |
962
-4,140
| -81% | -$641K | ﹤0.01% | 1573 |
|
|
2020
Q4 | $763K | Buy |
5,102
+1,225
| +32% | +$173K | ﹤0.01% | 1071 |
|
|
2020
Q3 | $512K | Buy |
3,877
+2,314
| +148% | +$302K | ﹤0.01% | 1121 |
|
|
2020
Q2 | $181K | Sell |
1,563
-1,212
| -44% | -$140K | ﹤0.01% | 1528 |
|
|
2020
Q1 | $272K | Buy |
+2,775
| New | +$364K | ﹤0.01% | 1121 |
|
|
2019
Q3 | – | Sell |
-797
| Closed | -$91K | – | 2034 |
|
|
2019
Q2 | $91K | Hold |
797
| – | – | ﹤0.01% | 1382 |
|
|
2019
Q1 | $99K | Sell |
797
-8,171
| -91% | -$929K | ﹤0.01% | 1525 |
|
|
2018
Q4 | $903K | Buy |
8,968
+8,171
| +1,025% | +$919K | ﹤0.01% | 758 |
|
|
2018
Q3 | $102K | Hold |
797
| – | – | ﹤0.01% | 1201 |
|
|
2018
Q2 | $86K | Hold |
797
| – | – | ﹤0.01% | 1277 |
|
|
2018
Q1 | $84K | Hold |
797
| – | – | ﹤0.01% | 1259 |
|
|
2017
Q4 | $93K | Hold |
797
| – | – | ﹤0.01% | 1111 |
|
|
2017
Q3 | $91K | Hold |
797
| – | – | ﹤0.01% | 1021 |
|
|
2017
Q2 | $99K | Hold |
797
| – | – | ﹤0.01% | 1032 |
|
|
2017
Q1 | $95K | Sell |
797
-59
| -7% | -$6.69K | ﹤0.01% | 1136 |
|
|
2016
Q4 | $86K | Sell |
856
-274,531
| -100% | -$29.4M | ﹤0.01% | 1115 |
|
|
2016
Q3 | $34.8M | Buy |
275,387
+275,328
| +466,658% | +$34M | 0.17% | 136 |
|
|
2016
Q2 | $7K | Buy |
+59
| New | +$6.68K | ﹤0.01% | 1262 |
|
|
2014
Q4 | – | Sell |
-5,437
| Closed | -$530K | – | 1336 |
|
|
2014
Q3 | $530K | Sell |
5,437
-86,808
| -94% | -$8.54M | ﹤0.01% | 666 |
|
|
2014
Q2 | $9.3M | Sell |
92,245
-13,282
| -13% | -$1.3M | 0.05% | 291 |
|
|
2014
Q1 | $9.69M | Buy |
105,527
+94,470
| +854% | +$8.71M | 0.05% | 252 |
|
|
2013
Q4 | $1M | Buy |
+11,057
| New | +$957K | 0.01% | 578 |
|
Other funds holding ZBH
VCM
VPM
Acadian Asset Management's ZBH Position: Q2 2026 in Review
Acadian Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 510 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.
Acadian Asset Management first reported a position in ZBH in Q4 2013 and has held it in 43 quarters since. The position peaked at $34.8M in Q3 2016. 731 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Acadian Asset Management held 510 shares of Zimmer Biomet worth $43K as of Q2 2026.
- Acadian Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1869 holding.
- Acadian Asset Management first reported a position in Zimmer Biomet in Q4 2013 and has held it in 43 quarters since.
- Acadian Asset Management's Zimmer Biomet position peaked at $34.8M in Q3 2016.
- 731 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.